ELIZABETH WENGEL: Open Payments
NPI 1144469917 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$76 in 4 payments from 4 companies in 2025. Trend: 2023 $367 · 2024 $1,449 · 2025 $76
Food & beverage: $76
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: CAPLYTA, ABILIFY MAINTENA, REXULTI, INVEGA SUSTENNA.
Industry payments across IL — which companies pay providers there.
